✦ LIBER ✦

No role for CXCL12–G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia

✍ Scribed by Ponziani, V; Mannelli, F; Bartalucci, N; Gianfaldoni, G; Leoni, F; Antonioli, E; Guglielmelli, P; Ciolli, S; Bosi, A; Vannucchi, A M

Book ID: 110058447
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 89 KB
Volume: 22
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404938

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute promyelocytic leukemia: a model fo

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

✍ Grimwade, D; Lo Coco, F 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 290 KB

New approaches for the detection of mini

New approaches for the detection of minimal residual disease in acute myeloid leukemia

✍ Anna van Rhenen; Bijan Moshaver; Gert J. Ossenkoppele; Gerrit Jan Schuurhuis 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 855 KB

mRNA expression of leukemia-associated a

mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

✍ Jochen Greiner; Mark Ringhoffer; Masanori Taniguchi; Li Li; Anita Schmitt; Hiros 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 1 views

## Abstract Specific immunotherapies for patients with acute myeloid leukemia (AML) using leukemia‐associated antigens (LAA) as target structures might be a therapeutic option to enhance the graft‐__vs__.‐leukemia effect observed after allogeneic stem cell transplantation or to prolong a complete r

Activated leukemic oncogenesAML1-ETOandc

Activated leukemic oncogenesAML1-ETOandc-kit: Role in development of acute myeloid leukemia and current approaches for their inhibition

✍ A. V. Rulina; P. V. Spirin; V. S. Prassolov 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 297 KB

The role of gemtuzumab ozogamicin in com

The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemia

✍ Hien K. Duong; Matt Kalaycio 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 178 KB

The synergy of panobinostat plus doxorub

The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair

✍ Maiso, P; Colado, E; Ocio, E M; Garayoa, M; Martín, J; Atadja, P; Pandiella, A; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 545 KB